Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 16, 2019
Patent Application Number
15513820
Date Filed
October 12, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
Interleukin-15 muteins and other interleukin-15-related molecules are described, as well as methods of identifying interleukin-15 muteins and other interleukin-15-related molecules. Also described herein are modifications of the foregoing, which modifications may enhance a property (e.g., half-life) of the muteins or other molecules compared to human interleukin-15. Pharmaceutical compositions and methods of use are also described herein.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.